Taken together, these studies, along with our own, strongly suggest that E-cadherin plays a critical role in bladder cancer progression. Its reduced expression is a consistent marker of higher tumor stage, grade, and invasiveness. This evidence concerns the gene CDH1 and urinary bladder carcinoma.